# Gluten Ingestion Biomarkers in Patients w Gluten Sensitivity and Healthy Controls Peptides in Patients With Non-celiac Gluten Sensitivity and Healthy Patients: A Placebo-controlled Study

> **NCT02936297** · NA · COMPLETED · sponsor: **Thomas Jefferson University** · enrollment: 90 (actual)

## Conditions studied

- Non Celiac Gluten Sensitivity

## Interventions

- **DIETARY_SUPPLEMENT:** High dose Gluten
- **DIETARY_SUPPLEMENT:** Low dose Gluten
- **DIETARY_SUPPLEMENT:** Lactose free placebo

## Key facts

- **NCT ID:** NCT02936297
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2020-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02936297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02936297, "Gluten Ingestion Biomarkers in Patients w Gluten Sensitivity and Healthy Controls Peptides in Patients With Non-celiac Gluten Sensitivity and Healthy Patients: A Placebo-controlled Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02936297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
